Browse by author
Lookup NU author(s): Dr Catherine Bui
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
β1,4-Galactosyltransferase 7 (β4GalT7) is a key enzyme initiating glycosaminoglycan (GAG) synthesis. Based on in vitro and ex vivo kinetics studies and structure-based modelling, we molecularly characterized β4GalT7 mutants linked to the progeroid form of Ehlers-Danlos syndrome (EDS), a severe connective tissue disorder. Our results revealed that loss of activity upon L206P substitution due to altered protein folding is the primary cause for the GAG synthesis defect in patients carrying the compound A186D and L206P mutations. We showed that R270C substitution strongly reduced β4GalT7 affinity towards xyloside acceptor, thus affecting GAG chains formation. This study establishes the molecular basis for β4GalT7 defects associated with altered GAG synthesis in EDS. © 2010 Federation of European Biochemical Societies.
Author(s): Bui C, Talhaoui I, Chabel M, Mulliert G, Coughtrie M, Ouzzine M, Fournel-Gigleux S
Publication type: Article
Publication status: Published
Journal: FEBS Letters
Print publication date: 05/08/2010
ISSN (print): 0014-5793
ISSN (electronic): 1873-3468
Publisher: Elsevier BV
PubMed id: 20691685
Altmetrics provided by Altmetric